GAL and hepatocellular carcinoma: The inhibitory effects of free drugs on four types of tumor cells were comparable, and free drugs had the strongest antitumor activity on non-hepatoma cells, while Gal-pH-TanIIA-NSVs had the most powerful anti-tumor activity on hepatoma cells, which again confirmed that galactose-modified vesicles had hepatic targeting characteristics.